Question 1

What is Amphastar Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Amphastar Pharmaceuticals (AMPH) reported deferred tax assets and other non-current assets of $33.39M in Q2 2026.

Question 2

How has Amphastar Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Amphastar Pharmaceuticals's deferred tax assets and other non-current assets increased by 18.8% year-over-year, from $28.1M to $33.39M.

Question 3

What is the long-term trend for Amphastar Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 42.8% compound annual growth rate (CAGR), from $5.25M to $31.14M.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30, 2026	December 31, 2025
Finance lease right-of-use assets	152	221
Operating lease right-of-use assets	72,911	42,931
Goodwill and intangible assets, net	647,833	565,965
Other assets	33,392	31,135
Deferred tax assets	42,464	42,464
Total assets	$1,743,766	$1,629,299
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Amphastar Pharmaceuticals's deferred tax assets and other non-current assets.

Amphastar Pharmaceuticals AMPH Deferred Tax Assets and Other Non-Current Assets